Application Sponsors
Marketing Status
Application Products
001 | SOLUTION;INTRAVENOUS | 1050MG/30ML (35MG/ML) | 0 | LUSEDRA | FOSPROPOFOL DISODIUM |
FDA Submissions
TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 2008-12-08 | STANDARD |
CDER Filings
EISAI INC
cder:Array
(
[0] => Array
(
[ApplNo] => 22244
[companyName] => EISAI INC
[docInserts] => ["",""]
[products] => [{"drugName":"LUSEDRA","activeIngredients":"FOSPROPOFOL DISODIUM","strength":"1050MG\/30ML (35MG\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"LUSEDRA","submission":"FOSPROPOFOL DISODIUM","actionType":"1050MG\/30ML (35MG\/ML)","submissionClassification":"SOLUTION;INTRAVENOUS","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)